Search for Clinical Trial Results
Gliosarcoma - 27 Studies Found
Status | Study |
Active, not recruiting |
Study Name: DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors Condition: Glioblastoma or Gliosarcoma Date: 2014-07-20 Interventions:
|
Completed |
Study Name: Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas Condition:
Date: 2008-01-29 Interventions: Drug: Avastin and Temozolomide This is Phase II study with the combination of Avastin & Temozolomide |
Withdrawn |
Study Name: Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma Condition:
Date: 2015-11-04 Interventions:
|
Completed |
Study Name: Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma Condition:
Date: 2008-08-12 Interventions:
|
Completed |
Study Name: Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma Condition:
Date: 2007-09-04 Interventions:
|
Recruiting |
Study Name: NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery Condition:
Date: 2017-01-11 Interventions:
|
Completed |
Study Name: Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients Condition:
|
Completed |
Study Name: Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma Condition:
|
Completed |
Study Name: Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas Condition:
|
Recruiting |
Study Name: BPM31510 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Previously Treated With Bevacizumab Condition:
Date: 2017-01-05 Interventions:
|